Skip to main content
Clinical Trials/CTRI/2018/10/016065
CTRI/2018/10/016065CompletedPhase 3

A Comparative Effectiveness Study of 50 Millesimal Potencies and Centesimal Potencies in the Treatment of Tinea Corporis: An Open, Randomized, Pragmatic Trial

DNDe Homoeopathic Medical College and Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Diagnosed case of Tinea corporis, suffering for at least 3 months (ICD 10 B35.4)
  • 2. Age 18-65 yrs
  • 3. Both sexes
  • 4. Literate patients who are able to read or write
  • 5. Patient using topical agents for tinea lesions will be included after a washout period of two weeks

Exclusion Criteria

  • 1. Cases with complications like lichenification and eczematisation
  • 2. Similar looking skin conditions; e.g. seborrhic dermatitis, pityriasis rosea and some types of psoriasis
  • 3. Patients who are too sick for consultation, unable to read patient information sheet, unwilling to take part or not giving consent to join the study
  • 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
  • 5. Pregnant women and lactating mothers
  • 6. Substance abuse and/or dependence
  • 7. Self-reported immune-compromised state, and
  • 8. Already undergoing homeopathic treatment for chronic disease within last 6 months

Investigators

Sponsor
DNDe Homoeopathic Medical College and Hospital

Similar Trials